What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?
Joseph Henry
Advertisement
Articles by Joseph Henry
In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.
Advertisement
Latest Updated Articles
Current Practices and Considerations for a Stability-Indicating Method in Pharmaceutical AnalysisPublished: March 1st 2014 | Updated:
Current Practices and Considerations for a Stability-Indicating Method in Pharmaceutical AnalysisPublished: August 1st 2014 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5